Ovid Therapeutics Inc

NASDAQ:OVID  
3.20
-0.04 (-1.24%)
Earnings Announcements

Ovid Therapeutics Reports Q3 Loss Per Share $0.28

Published: 11/10/2021 14:05 GMT
Ovid Therapeutics Inc (OVID) - Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial Results.
Ovid Therapeutics Inc - Q3 Loss per Share $0.28.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.